📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: CD Diagnostics

1.1 - Company Overview

CD Diagnostics Logo

CD Diagnostics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of diagnostic assays for orthopedic surgeons and rheumatologists, designed to provide greater diagnostic confidence in joint fluid analysis, including Synovasure® diagnostic product offerings and CygnaSureâ„¢ as the lead product, which offers rapid, accurate and reliable diagnostic.

Products and services

  • CygnaSure™: Clinical-grade lead assay that delivers rapid, accurate, and reliable diagnostic results for orthopedic surgeons and rheumatologists seeking greater diagnostic confidence in joint fluid analysis
  • Synovasure® Diagnostic Product Offerings: Laboratory-grade range of diagnostic assays engineered to give orthopedic surgeons and rheumatologists greater diagnostic confidence in joint fluid analysis
  • Assay Development for Joint Fluid Analysis: Custom-engineered development of assays enabling orthopedic surgeons and rheumatologists to achieve greater diagnostic confidence specifically in joint fluid analysis

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to CD Diagnostics

Ottobock Logo

Ottobock

HQ: Germany Website
  • Description: Provider of prosthetic and orthotic medical devices serving people with mobility challenges around the world, focused on improving quality of life through freedom of movement and independence.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ottobock company profile →
EpiBone Logo

EpiBone

HQ: United States Website
  • Description: Provider of 3D-designed, cell-based bone reconstruction. Uses CT imaging to size and shape needed bone, extracts adult stem cells from abdominal fat, designs personalized grafts and custom bioreactors, and grows stem cell–seeded scaffolds into implant-ready bone. Features proprietary bioreactor technology that mimics human body conditions to support bone growth.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EpiBone company profile →
Zeda Logo

Zeda

HQ: United States Website
  • Description: Provider of advanced manufacturing services to medical, space, defense, and aerospace industries, combining expertise in additive manufacturing (AM), nanotechnology, and precision manufacturing; also invests in cutting-edge technologies, innovative companies, and groundbreaking ideas. Formerly PrinterPrezz/Vertex Manufacturing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zeda company profile →
Sirakoss Logo

Sirakoss

HQ: United Kingdom Website
  • Description: Provider of synthetic bone graft substitutes, offering granular and putty forms of its proprietary MaxSi technology for trauma, spine, craniomaxillofacial and dental applications, and a nanosynthetic bone graft putty designed for dual bone formation pathways for use in spinal and orthopedic surgeries.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sirakoss company profile →
Orliman Logo

Orliman

HQ: France Website
  • Description: Provider of orthopedic products. Originating as a Spanish family orthopedic business more than 70 years ago, Orliman was established as a limited company in the last decade to develop and mass-produce orthopedic products, with a strategy focused on constant research, product quality and performance, and personalized service.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orliman company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for CD Diagnostics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to CD Diagnostics

2.2 - Growth funds investing in similar companies to CD Diagnostics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for CD Diagnostics

4.2 - Public trading comparable groups for CD Diagnostics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to CD Diagnostics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About CD Diagnostics

What does CD Diagnostics do?

CD Diagnostics is a provider of diagnostic assays for orthopedic surgeons and rheumatologists, designed to provide greater diagnostic confidence in joint fluid analysis, including Synovasure® diagnostic product offerings and CygnaSure™ as the lead product, which offers rapid, accurate and reliable diagnostic.

Who are CD Diagnostics's competitors?

CD Diagnostics's competitors and similar companies include Ottobock, EpiBone, Zeda, Sirakoss, and Orliman.

Where is CD Diagnostics headquartered?

CD Diagnostics is headquartered in United States.

How many employees does CD Diagnostics have?

CD Diagnostics has 1,000 employees 🔒.

When was CD Diagnostics founded?

CD Diagnostics was founded in 2010 🔒.

What sector and industry vertical is CD Diagnostics in?

CD Diagnostics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for CD Diagnostics

Who are the top strategic acquirers in CD Diagnostics's sector and industry

Top strategic M&A buyers and acquirers in CD Diagnostics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for CD Diagnostics?

Top strategic M&A buyers groups and sectors for CD Diagnostics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in CD Diagnostics's sector and industry vertical

Which are the top PE firms investing in CD Diagnostics's sector and industry vertical?

Top PE firms investing in CD Diagnostics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in CD Diagnostics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in CD Diagnostics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in CD Diagnostics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to CD Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in CD Diagnostics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for CD Diagnostics?

The key public trading comparables and valuation benchmarks for CD Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for CD Diagnostics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for CD Diagnostics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in CD Diagnostics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for CD Diagnostics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in CD Diagnostics's' sector and industry vertical?

Access recent funding rounds and capital raises in CD Diagnostics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for CD Diagnostics